LAUSR

Dashboard-Driven Accelerated Infliximab Induction Dosing Increases Infliximab Durability and Reduces Immunogenicity.

Sign Up to like & get
recommendations!
1 Published in 2022 at "Inflammatory bowel diseases"

DOI: 10.1093/ibd/izab285

Abstract: BACKGROUND AND AIMS Accelerated infliximab (IFX) induction is often based on clinical parameters as opposed to pharmacokinetics (PK). We aimed to investigate the impact of dashboard-guided optimized induction dosing on IFX durability and immunogenicity in… read more here.

Keywords: accelerated infliximab; induction dosing; durability; immunogenicity ... See more keywords